Ulcerative Colitis
📧 Sign up to get email alerts when something new happens for Ulcerative Colitis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2025-05-31Clinical Trial Update: Anti-tumor Necrosis Factor in Patients With Ulcerative Colitis in Clinical Remission: to Continue or Not? [NA]
A clinical trial assessing whether to continue anti-TNF therapy in patients with ulcerative colitis in clinical remission has completed. The…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Efficacy and Safety of Discontinuing 5-ASA in Patients With Inflammatory Bowel Disease [NA]
This clinical trial update assesses the efficacy and safety of discontinuing 5-ASA therapy in patients with inflammatory bowel disease, incl…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Impact of Anti-TNF, Vedolizumab and Tofacitinib on Aortic Stiffness, Carotid Intima-media Thickness and Cardiovascular Risk of Patients With Ulcerative Colitis [Phase 4]
A Phase 4 clinical trial evaluating anti-TNF therapy, vedolizumab, and tofacitinib on vascular measures in ulcerative colitis. Recruitment i…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: Investigation of the Correlation Between Polyamine Levels and Their Key Enzymatic Activities in Association With Inflammatory Bowel Disease Progression
A clinical trial investigating whether polyamine levels and the activity of their key enzymes correlate with the progression of inflammatory…
-
CLINICAL_TRIALS research · 2025-05-29Clinical Trial Update: NAZA - Nottingham/Astra ZenecA Prospective IBD Cohort Study
This clinical trial update shows a prospective inflammatory bowel disease (IBD) cohort study conducted in Nottingham is currently recruiting…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
FDA approval · 2025-05-29FDA Approved: MESALAMINE — Supplemental Application (Lannett Company Inc.)
FDA approved a supplemental application for Mesalamine (generic) from Lannett Company Inc., for the treatment of ulcerative colitis.
-
CLINICAL_TRIALS research · 2025-05-25Clinical Trial Update: Transcutaneous Electrical Acustimulation in the Treatment of Mild to Moderate Ulcerative Colitis [NA]
A clinical trial is evaluating transcutaneous electrical acustimulation for mild to moderate ulcerative colitis and is currently recruiting …
-
FDA approval · 2025-05-22FDA Approved: STARJEMZA — Original Application (Hikma Pharmaceuticals USA Inc.)
FDA approved STARJEMZA (ustekinumab-hmny) from Hikma Pharmaceuticals USA Inc. as a biosimilar to ustekinumab, enabling marketing for the sam…
-
CLINICAL_TRIALS research · 2025-05-16Clinical Trial Update: Pharmacokinetics of IFX and TNF Concentrations in Serum, Stool, and Colonic Mucosa in Acute Severe Ulcerative Colitis
A pharmacokinetic study evaluating infliximab and TNF concentrations in serum, stool, and colonic mucosa in patients with acute severe ulcer…
-
CLINICAL_TRIALS research · 2025-05-15Clinical Trial Update: Comparison of Ustekinumab, Infliximab and Combination Therapy in Moderately to Severely Active Ulcerative Colitis [Phase 2]
Phase 2 clinical trial comparing Ustekinumab, Infliximab, and their combination in moderately to severely active Ulcerative Colitis; the stu…
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Adjunctive Treatment With Vitamin D3 in Patients With Active IBD [NA]
A clinical trial evaluating adjunctive vitamin D3 in patients with active inflammatory bowel disease has been suspended.
-
CLINICAL_TRIALS trial_result · 2025-05-09Clinical Trial Update: Effect of a Probiotic Mixture on the Gut Microbiome and Fatigue in Patients With Quiescent Inflammatory Bowel Disease [NA]
A clinical trial evaluating a probiotic mixture for gut microbiome changes and fatigue in patients with quiescent inflammatory bowel disease…
-
CLINICAL_TRIALS trial_result · 2025-05-08Clinical Trial Update: An Analysis of the Relationship Between the Genetic Polymorphisms of Plasminogen Activator Inhibitor-1 and Ulcerative Colitis in Chinese Patients
Completed clinical trial examining the relationship between genetic polymorphisms of plasminogen activator inhibitor-1 and ulcerative coliti…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Study of Efficacy and Adherence to Subcutaneous vs. Intravenous Vedolizumab in Patients With Inflammatory Bowel Disease Using a Novel Remote MONITORing Intervention
Clinical trial protocol comparing subcutaneous and intravenous vedolizumab for inflammatory bowel disease, incorporating a remote monitoring…
-
CLINICAL_TRIALS research · 2025-05-08Clinical Trial Update: Enhancing Endoscopic Scoring Consistency and Accuracy in IBD: a Video-based Training Approach [NA]
This clinical trial update describes a video-based training approach intended to improve the consistency and accuracy of endoscopic scoring …
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: Evaluation of Molecular Mechanisms of Non-response to Therapy in Patients With Inflammatory Bowel Disease [NA]
A clinical trial in France is investigating molecular mechanisms behind non-response to therapy in inflammatory bowel disease (Crohn's disea…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: The Diagnostic Value of Serum Oncostatin M and Galactin 3 as Biomarkers in Diagnosis of Ulcerative Colitis Disease [NA]
A clinical trial is investigating whether serum Oncostatin M and Galectin-3 can serve as diagnostic biomarkers for ulcerative colitis. The s…
-
CLINICAL_TRIALS research · 2025-05-06Clinical Trial Update: A Study to Evaluate Biomarkers in Moderate to Severe Ulcerative Colitis (UC) Patients Treated With Different Targeted Therapies
A clinical trial is evaluating biomarkers in moderate to severe Ulcerative Colitis patients treated with different targeted therapies. The s…
-
CLINICAL_TRIALS trial_result · 2025-05-06Clinical Trial Update: Janus Kinase Inhibitors for the Treatment of Acute Severe Ulcerative Colitis
This clinical trial update reports the completion of a study evaluating Janus kinase inhibitors for acute severe ulcerative colitis.
-
CLINICAL_TRIALS trial_result · 2025-05-04Clinical Trial Update: Prevalence and Factors Associated With Sleep Disorders in Inflammatory Bowel Disease [NA]
A completed clinical trial examining how common sleep disorders are in inflammatory bowel disease and identifying factors associated with th…
-
CLINICAL_TRIALS research · 2025-05-02Clinical Trial Update: Texture and Color Enhancement Imaging (TXI) for Inflammation Assessment in Patients With Inflammatory Bowel Diseases [NA]
A University of Ulm clinical study is evaluating Texture and Color Enhancement Imaging (TXI) as a noninvasive way to assess inflammation in …
-
CLINICAL_TRIALS trial_result · 2025-05-02Clinical Trial Update: Enhancing Ultrasound & Photoacoustic for Recognition of Intestinal Abnormalities
The clinical trial sponsored by iThera Medical GmbH evaluating ultrasound and photoacoustic imaging to recognize intestinal abnormalities in…
-
CLINICAL_TRIALS research · 2025-05-01Clinical Trial Update: Therapeutic Drug Monitoring for Biological Therapy in Pediatric Inflammatory Bowel Disease
A pediatric trial from Medical University Innsbruck is investigating therapeutic drug monitoring to optimize biological therapy for inflamma…
-
FDA approval · 2025-04-30FDA Approved: USTEKINUMAB-TTWE — Original Application (Quallent Pharmaceuticals Health LLC)
FDA approves an original biologics license application for USTEKINUMAB-TTWE from Quallent Pharmaceuticals Health LLC.
-
FDA approval · 2025-04-30FDA Approved: SELARSDI — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for SELARSDI (ustekinumab-aekn) from Teva Pharmaceuticals USA, Inc., representing an approval of a b…